Movano (NASDAQ:MOVE) Stock Passes Above 200-Day Moving Average – Here’s Why

Posted by Stanley Muller on Jun 11th, 2026

Movano Inc. (NASDAQ:MOVE – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $13.22 and traded as high as $18.23. Movano shares last traded at $16.70, with a volume of 34,775 shares trading hands.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

Positive Sentiment: Movano’s stock moved above its 200-day moving average, which may be seen as a bullish technical breakout and a sign of improving investor sentiment. Movano (NASDAQ:MOVE) Share Price Crosses Above Two Hundred Day Moving Average – Here’s Why

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Movano from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Research Report on Movano

Movano Stock Performance

The company has a 50-day moving average of $17.09 and a 200 day moving average of $13.32. The company has a quick ratio of 2.04, a current ratio of 2.14 and a debt-to-equity ratio of 4.28. The firm has a market capitalization of $20.48 million, a PE ratio of -1.32 and a beta of 0.86.

Movano (NASDAQ:MOVE – Get Free Report) last posted its earnings results on Tuesday, May 19th. The technology company reported ($3.13) EPS for the quarter, missing the consensus estimate of ($2.65) by ($0.48). Movano had a negative return on equity of 647.91% and a negative net margin of 2,462.55%.The business had revenue of $0.51 million for the quarter, compared to analysts’ expectations of $7.63 million.

Hedge Funds Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new position in shares of Movano Inc. (NASDAQ:MOVE – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano as of its most recent SEC filing. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Movano Company Profile

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.